DOI: https://doi.org/10.30841/2307-5112.1(69).2017.103099

The use of phytomedicine Solidahoren® in nephropathies and urinary tract infections

В. О. Мойсеєнко, Т. Д. Никула, Т. Б. Брижаченко, І. В. Пасько, Ю. П. Михальчишин

Abstract


The aim of the research: to study the dynamics of clinical and labora tory parameters under the influence of phytomedicine Solidagoren® in patients with primary and secondary nephropathies and urinary tract infections.

Materials and methods. In an open randomized study with concur rent control took part 52 patients (24 men and 28 women) with chronic kidney disease (CKD): chronic tubulo interstitial nephritis (TIN), pyelonephritis (P) in the acute stage. The main group (A) included 37 patients, the control group (C) included 15. The average age of the surveyed was 38.9±8.6 years. 31 patients were diagnosed with CKD of I stage, 21 II stage. The influence of the medicine Solidagoren® was studied in two phases: stationary (10 14 days) and outpatient (6 weeks).

Results. The inclusion of the medicine Solidagoren® in complex treat ment of patients with CKD of I II stage allows to achieve the desired therapeutic effect faster than in the control group. Patients receiving the medicine Solidagoren® occurred significant reduction in erythro cyte sedimentation rate, level of proteinuria, erythrocyturia and the downward trend in the level of blood urea, increase of hemoglobin lev els in patients with the low level at the beginning of treatment, there also was an increase in glomerular filtration rate. After the treatment, adherence to treatment medicine Solidagoren® was expressed by more than 84% of the respondents.

Conclusion. Phytomedicine Solidagoren® , which has a broad spec trum of activity, can be successfully used for the treatment and sec ondary prevention of many diseases of the urinary system.


Keywords


nephropathy; urinary tract infection; treatment; Solidahoren®

References


Амброзюк О.Б. Марчишин С.М. Дослідження полісахаридного комплексу трави перстачу гусячого (Potentilla anserine l). – Медична хімія. – 2011. – Т. 13, No 1. – С. 123–125.

Никула Т.Д., Палієнко І.А. Фітотерапія в нефрології. – К.: НМУ, 1995. – 224 с.

Мойсеєнко В.О., Никула Т.Д., Буржинська І.В. Хронічна хвороба нирок і вісцеральні кандидози // Український журнал нефрології та діалізу Ukrainian journal of nephrology and dialysis. – 2015. – No 4 (48). – С. 61–64.

Assessment report on Solidago virgaurea L. herba // European Medicines Agency. – 2008.

Brantner A. The antimicrobial activity of Solidago containing phytourologica // Drogen report. – 1999. – V. 12. – P. 27–28.

Echtes Goldenrutenkraut als entzün dungshemmende Droge / Melzig M.F., Löser B., Bader G., Papsdorf G. // Z. Phytother. – 2000. – V. 21. – P. 67–70.

Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assays / Sampson J.H., Phillipson J.D., Bowery N.G. et al. // Phytother Res. – 2000. – V. 14, No 1. – P. 24–9.

Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction / Borchert V.E., Czyborra P., Fetscher C. et al. // Naunyn Schmiedebergs Arch. Pharmacol. – 2004. – V. 369, No 3. – P. 281–286.

European Goldenrod // Herbal Medicines. – 4th edition. – 2013. – 928 p.

Immunobiological activity of a new benzyl benzoate from the aerial part sof Solidago virgaurea var. gigantea / Choi S.Z., Choi S.U., Bae S.Y. et al. // Arch. Pharm. Res. – 2005. – V. 28. – P. 49–54.

Immunomodulatory and antitumoral effects of triterpenoid saponins / Plohmann B., Bader G.T., Hiller K., Franz G. // Pharmazie. – 1997. – V. 12. – P. 953–957.

Immunmodulatorische und antitu morale Aktivität von Tri terpensaponinen aus Solidago virgaurea L. / Plohmann B., Franz G., Bader G., Hiller K. // Drogenreport. – 1999. – V. 12. – P. 29–30.

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society / Gupta K., Hooton T.M., Naber K.G. et al. // Clin. Infect. Dis. – 2011. – V. 52, No 5. – P. e103 –e120; doi: 10.1093/cid/ciq257.

Kalemba D. Constituents and biological activity of the essential oils of some Solidago and Artemisia species // Scientific Papers Technical University of Lodz. – 2000. – V. 857. – P. 1–118.

Klinisch Experimentelle Studie Nr 23223. P 1. 1992. Bioforce AG.

Klinisch Experimentelle Studie Nr 23223. P 2. 1992. Bioforce AG.

Klinische Anwendungsbeobach tungen zur Wirksamkeit und Sicherheitbei Monographie konformem Einsatzeines Goldruten extrakt Prдparates / Laszig R., Smiszek R., Stammwitz U. et al. // Drogenreport. – 1999. – V. 12. – P. 38–40.

Kolodziej B., Kowalski K., Kêdzia B. Antibacterial and antimuta genic activity of extracts aboveground parts of three Solidago species: Solidago virgaurea L., Solidago canadensis L. and Solidago gigantea Ait. // Journal of Medicinal Plants Research. – 2011. – V. 5, No 31. — P. 6770–6779.

Metzner J., Hirschelmann R., Hiller K. Antiphlogistische und analgetische Wirkungen von Leiocarposid, einem phenolischen Bisglucosid aus Solidago virgaurea L. // Pharmazie. – 1984. – V. 39. – P. 869–870.

Meyer B., Schneider W., Elstner E.F. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. – 1995. – V. 45, No 2. – P. 174–176.

Pepeljnjak S., Kustrak D., Vukusic I. Investigation of the antimycotic activity of Solidago virgaurea and Solidago gigantea extracts // Pharm. Pharmacol. Lett. – 1998. – V. 8. – P. 85–86.

Pfannkuch A., Stammwitz U. Wirksamkeit und Vertrдglichkeit eines monographiekonformen Goldrutenkraut Extraktes bei Patienten mit Reizblase // Ztschr. Phytother. – 2002. – V. 23. – P. 20–25.

Schakau D. Solidago Steiner® Tabletten. Solidago Steiner® Lцsung und Harntee Steiner® // Portfolio Schulung. – Januar, 2014.]

Schmitt M. Echte Goldrute normaliesiert die Reizblase. Effective und neben wirkungsarme Behandlung abakterieller Cystiden // TW Urologie Nephrologie. – 1996. – V. 8. – P. 133–135.

Strehl E., Schneider W., Elstner E.F. Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. – 1995. – V. 45, No 2. – P. 172–173.

Thiem B., Gosliñska O. Antimicrobial activity of Solidago virgaurea L. from in vitro cultures // Fitoterapia. – 2002. – V. 73, No 6. – P. 514–516.

Triterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast hyphal conversion / Laurençon L., Sarrazin E., Chevalier M. et al. // Phytochemistry. – 2013. – V. 86. — P. 103–111.




Copyright (c) 2020 В. О. Мойсеєнко, Т. Д. Никула, Т. Б. Брижаченко, І. В. Пасько, Ю. П. Михальчишин

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter

ISSN (print): 2307-5112.